JPWO2023049803A5 - - Google Patents
Info
- Publication number
- JPWO2023049803A5 JPWO2023049803A5 JP2024517427A JP2024517427A JPWO2023049803A5 JP WO2023049803 A5 JPWO2023049803 A5 JP WO2023049803A5 JP 2024517427 A JP2024517427 A JP 2024517427A JP 2024517427 A JP2024517427 A JP 2024517427A JP WO2023049803 A5 JPWO2023049803 A5 JP WO2023049803A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- recombinant polypeptide
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163247239P | 2021-09-22 | 2021-09-22 | |
| US63/247,239 | 2021-09-22 | ||
| PCT/US2022/076862 WO2023049803A1 (en) | 2021-09-22 | 2022-09-22 | Il5ra cell surface markers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024534499A JP2024534499A (ja) | 2024-09-20 |
| JP2024534499A5 JP2024534499A5 (https=) | 2025-09-30 |
| JPWO2023049803A5 true JPWO2023049803A5 (https=) | 2025-09-30 |
Family
ID=85721256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024517427A Pending JP2024534499A (ja) | 2021-09-22 | 2022-09-22 | Ｉｌ５ｒａ細胞表面マーカー |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240417443A1 (https=) |
| EP (1) | EP4405383A4 (https=) |
| JP (1) | JP2024534499A (https=) |
| KR (1) | KR20240069766A (https=) |
| CN (2) | CN118251407A (https=) |
| AU (1) | AU2022349077A1 (https=) |
| CA (1) | CA3232203A1 (https=) |
| MX (1) | MX2024003250A (https=) |
| WO (1) | WO2023049803A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5453491A (en) * | 1990-09-11 | 1995-09-26 | Kiyoshi Takatsu | Murine interleukin-5 receptor |
| JP4756813B2 (ja) * | 2000-05-22 | 2011-08-24 | フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー） | レセプターを用いた相互作用の捕捉法 |
| HUE036885T2 (hu) * | 2007-05-14 | 2018-08-28 | Astrazeneca Ab | Eljárás a bazofil-szint csökkentésére |
| ES3053874T3 (en) * | 2015-08-24 | 2026-01-27 | Glaxosmithkline Ip No 2 Ltd | Biopharmaceutical compositions |
| JP2018538249A (ja) * | 2015-11-04 | 2018-12-27 | アストラゼネカ アクチボラグ | 好酸球性疾患における好酸球標的化治療薬に対する臨床応答の予測変数としてのジペプチジルペプチダーゼ−４およびペリオスチン |
| EP3635132A4 (en) * | 2017-06-07 | 2021-05-26 | Intrexon Corporation | EXPRESSION OF NOVEL CELL MARKERS |
| KR20240096884A (ko) * | 2020-03-10 | 2024-06-26 | 매사추세츠 인스티튜트 오브 테크놀로지 | 조작된 기억-유사 nk 세포 및 이의 조성물을 생성하기 위한 방법 |
-
2022
- 2022-09-22 MX MX2024003250A patent/MX2024003250A/es unknown
- 2022-09-22 AU AU2022349077A patent/AU2022349077A1/en active Pending
- 2022-09-22 EP EP22873860.5A patent/EP4405383A4/en active Pending
- 2022-09-22 KR KR1020247012657A patent/KR20240069766A/ko active Pending
- 2022-09-22 CN CN202280074739.XA patent/CN118251407A/zh active Pending
- 2022-09-22 CN CN202411599318.6A patent/CN119661725A/zh active Pending
- 2022-09-22 US US18/693,418 patent/US20240417443A1/en active Pending
- 2022-09-22 CA CA3232203A patent/CA3232203A1/en active Pending
- 2022-09-22 WO PCT/US2022/076862 patent/WO2023049803A1/en not_active Ceased
- 2022-09-22 JP JP2024517427A patent/JP2024534499A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107531800B (zh) | 用于嵌合抗原受体分子的调控表达的慢病毒载体 | |
| JP2021191265A5 (https=) | ||
| CN107404881A (zh) | 用于过继性t细胞疗法的中央记忆t细胞 | |
| CN111892661B (zh) | 一种嵌合抗原受体及其在制备治疗肿瘤的产品中的应用 | |
| KR20170012324A (ko) | 키메라 항원 수용체 단백질을 코딩하는 핵산 및 키메라 항원 수용체 단백질을 발현하는 t 림프구 | |
| HU230364B1 (hu) | Simian adenovírus nukleinsav és aminosav-szekvencia, azt tartalmazó vektorok, és eljárások annak alkalmazására | |
| JP2021525534A5 (https=) | ||
| KR970702065A (ko) | 증강된 바이러스-매개된 DNA 전이 (Enhanced virus-mediated DNA transfer) | |
| CA2233316A1 (en) | Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains | |
| CN112079932A (zh) | 一种用于肝癌治疗的嵌合抗原受体及其应用 | |
| EP4021932B1 (en) | Tcr constructs specific for ebv-derived antigens | |
| US20230227575A1 (en) | Engineered T Cells | |
| CN108728460A (zh) | 靶向gd2的嵌合抗原受体及其用途 | |
| CN111875708A (zh) | 一种嵌合抗原受体t淋巴细胞及其在制备治疗实体肿瘤的产品中的应用 | |
| CN116997654A (zh) | 编码抗乙酰胆碱受体自身抗体的嵌合受体的基因 | |
| WO1997024446A2 (en) | Gene delivery vehicle-targeting ligands | |
| WO2020253879A1 (zh) | 一种双特异性嵌合抗原受体 | |
| JPWO2019236577A5 (https=) | ||
| IE60285B1 (en) | Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom | |
| CN106755109A (zh) | 一种表达人cd19和cd20嵌合抗原受体基因的慢病毒载体 | |
| CN115947824A (zh) | 突变的人源t细胞受体恒定区、t细胞受体及t细胞受体修饰的细胞及应用 | |
| JPWO2022216514A5 (https=) | ||
| KR20200064107A (ko) | 쥐 불변 영역을 갖는 tcr을 발현하는 세포를 선택적으로 확대시키는 방법 | |
| CN111499766B (zh) | 针对慢性淋巴细胞白血病的免疫效应细胞、其制备方法和应用 | |
| JP2000503850A (ja) | Ｓ―層―タンパク質の組み換え発現 |